NCT02632578View on ClinicalTrials.gov

Influenza Vaccine in HIV Study

CompletedOBSERVATIONAL
Enrollment

57

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

December 31, 2015

Conditions
Influenza, Human
Interventions
BIOLOGICAL

2015 Fluvax® vaccine, BioCSL (a licensed influenza vaccine)

Subjects received licensed influenza vaccine (Fluvax®), 1ml intramuscular injection.

All Listed Sponsors
lead

University of Melbourne

OTHER

NCT02632578 - Influenza Vaccine in HIV Study | Biotech Hunter | Biotech Hunter